Moneycontrol PRO
HomeNewsMankind pharma

Mankind Pharma

Jump to
  • Buy Mankind Pharma; target of Rs 1,132: Motilal Oswal

    Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2,800 in its research report dated November 07, 2025.

  • Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y

    Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y

  • Stocks to Watch Today: Bharti Airtel, Lupin, TVS Motor, RVNL, Apollo Hospitals, Studds Accessories, GMM Pfaudler, Cummins, Amber Enterprises, Genus Power in focus on 07 November

    Stocks to Watch Today: Bharti Airtel, Lupin, TVS Motor, RVNL, Apollo Hospitals, Studds Accessories, GMM Pfaudler, Cummins, Amber Enterprises, Genus Power in focus on 07 November

    Stocks to Watch, 07 November: Stocks like Bharti Airtel, Lupin, TVS Motor Company, Rail Vikas Nigam, Apollo Hospitals Enterprise, Studds Accessories, GMM Pfaudler, Cummins, Amber Enterprises, Orkla India, Genus Power Infrastructures, and RBL Bank will be in focus on November 7.

  • Stocks to Watch Today: Tata Capital, DMart, Waaree Renewable, Phoenix Mills, Mahindra Lifespace, HCC, Travel Food, NTPC Green in focus on 13 October

    Stocks to Watch Today: Tata Capital, DMart, Waaree Renewable, Phoenix Mills, Mahindra Lifespace, HCC, Travel Food, NTPC Green in focus on 13 October

    Stocks to Watch, 13 October: Stocks like Avenue Supermarts, Waaree Renewable Technologies, Signature Global India, Phoenix Mills, Lupin, Mahindra Lifespace Developers, Hindustan Construction Company, Travel Food Services, NTPC Green Energy, Zen Technologies, Axis Bank, Computer Age Management Services,and Tata Capital will be in focus on October 13.

  • Trade Spotlight: How should you trade Kotak Mahindra Bank, Aadhar Housing, Kansai Nerolac, Kfin Tech, Mankind Pharma, Zydus Life, and others on September 19?

    Trade Spotlight: How should you trade Kotak Mahindra Bank, Aadhar Housing, Kansai Nerolac, Kfin Tech, Mankind Pharma, Zydus Life, and others on September 19?

    The market may see some consolidation, but overall, the mood remains bullish. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade Wipro, NLC India, Bharat Electronics, Mazagon Dock, VIP Industries, Hindustan Aeronautics, and others on September 11?

    Trade Spotlight: How should you trade Wipro, NLC India, Bharat Electronics, Mazagon Dock, VIP Industries, Hindustan Aeronautics, and others on September 11?

    The trend is likely to be upward despite consolidation (if any), as frontline indices now trade above all key moving averages. Below are some short-term trading ideas to consider.

  • Buy Mankind Pharma; target of Rs 2990: Motilal Oswal

    Buy Mankind Pharma; target of Rs 2990: Motilal Oswal

    Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2990 in its research report dated August 01, 2025.

  • Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y

    Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y

  • Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y

    Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y

  • Stocks to Watch Today: Coal India, Shanti Gold, Swiggy, PB Fintech, Chalet Hotels, RR Kabel, JSW Energy, Aarti Industries, ITC, Eicher Motors in focus on 1 August

    Stocks to Watch Today: Coal India, Shanti Gold, Swiggy, PB Fintech, Chalet Hotels, RR Kabel, JSW Energy, Aarti Industries, ITC, Eicher Motors in focus on 1 August

    Stocks to Watch Today, 1 August: Stocks like Coal India, Shanti Gold International, Swiggy, PB Fintech, Chalet Hotels, RR Kabel, JSW Energy, Aarti Industries, ITC, Eicher Motors, and Gujarat Gas will be in focus on August 1.

  • Gainers & Losers: Top 10 stocks that moved the most on July 11

    Gainers & Losers: Top 10 stocks that moved the most on July 11

    About 1510 shares advanced, 2341 shares declined, and 150 shares were unchanged.

  • Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y

    Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y

  • Indian pharma companies sit on record cash pile, set sights on acquisitions

    Indian pharma companies sit on record cash pile, set sights on acquisitions

    In FY25 alone, the cash pile increased by over Rs 10,200 crore, underscoring a decisive shift in the capital allocation priorities of India’s drugmakers

  • Buy Mankind Pharma; target of Rs 2910: Motilal Oswal

    Buy Mankind Pharma; target of Rs 2910: Motilal Oswal

    Motilal Oswal is bullish on Mankind Pharma recommended buy rating on the stock with a target price of Rs 2910 in its research report dated May 22, 2025.

  • Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y

    Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y

  • Mankind Pharma Standalone March 2025 Net Sales at Rs 2,126.59 crore, down 1.21% Y-o-Y

    Mankind Pharma Standalone March 2025 Net Sales at Rs 2,126.59 crore, down 1.21% Y-o-Y

  • Stocks to Watch Today: IndiGo, IndusInd Bank, Colgate, NALCO, Hindustan Zinc, NBCC, Aarti Industries, Birlasoft, MGL, Oil India in focus on 22 May

    Stocks to Watch Today: IndiGo, IndusInd Bank, Colgate, NALCO, Hindustan Zinc, NBCC, Aarti Industries, Birlasoft, MGL, Oil India in focus on 22 May

    Stocks to Watch, 22 May: Stocks like NBCC (India), Jindal Poly Films,Hindustan Zinc,Data Patterns (India), Zinka Logistics Solutions, KPR Mill, Aarti Industries, Birlasoft, Hindustan Copper, Gallantt Ispat, Geojit Financial Services, Teamlease Services, Mankind Pharma, Astral, GMM Pfaudler, Rail Vikas Nigam, IRCON International, VA Tech Wabag, and Oil India will be in focus on May 22.

  • Bulk deals: BOFA Securities Europe SA acquires 1.68% stake in Angel One, 0.72% shares in Nuvama Wealth

    Bulk deals: BOFA Securities Europe SA acquires 1.68% stake in Angel One, 0.72% shares in Nuvama Wealth

    Angel One shares closed at Rs 2,328.50, down 0.23 percent, while Nuvama Wealth Management stock rose 1.25 percent to Rs 5,944.

  • Stocks to Watch Today: Tata Motors, Paytm, TVS Motor, NLC India, Piramal Enterprises, International Gemmological Institute, M&M in focus on 3 March

    Stocks to Watch Today: Tata Motors, Paytm, TVS Motor, NLC India, Piramal Enterprises, International Gemmological Institute, M&M in focus on 3 March

    Stocks To Watch, Mar 3: Stocks like Foseco India, Rana Sugars, Maruti Suzuki India, Hyundai Motor India, Eicher Motors, Escorts Kubota, SML Isuzu, Atul Auto, VST Tillers, Dr Agarwals Health Care, Bajaj Auto, Indian Overseas Bank, Voltas, Mankind Pharma, Ujjivan Small Finance Bank, Dalmia Bharat, and Tata Communications will be in focus on March 3.

  • Mankind Pharma divests stake in Mahananda Spa to Chalet Hotels at Rs 530 crore Enterprise Value

    Mankind Pharma divests stake in Mahananda Spa to Chalet Hotels at Rs 530 crore Enterprise Value

    The Share Purchase Agreement will be executed soon, said Mankind Pharma, and the transaction will be completed by February 28, 2025. Mahananda Spa had a turnover of Rs 74.33 crore in FY24, and a networth of Rs 401.35 crore.

  • Trade Spotlight: How should you trade Bajaj Finance, Mankind Pharma, ITC, Deepak Nitrite, IndusInd Bank, SBI Card, and others on February 4?

    Trade Spotlight: How should you trade Bajaj Finance, Mankind Pharma, ITC, Deepak Nitrite, IndusInd Bank, SBI Card, and others on February 4?

    As long as the market defends the midline of Bollinger Bands, the trend may remain in favour of bulls despite Monday's profit booking. Below are some trading ideas for the near term.

  • Buy Mankind Pharma; target of Rs 3050: Motilal Oswal

    Buy Mankind Pharma; target of Rs 3050: Motilal Oswal

    Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 3050 in its research report dated January 25, 2025.

  • Mankind Pharma Consolidated December 2024 Net Sales at Rs 3,230.00 crore, up 23.9% Y-o-Y

    Mankind Pharma Consolidated December 2024 Net Sales at Rs 3,230.00 crore, up 23.9% Y-o-Y

  • Mankind Pharma Standalone December 2024 Net Sales at Rs 2,396.57 crore, up 1.61% Y-o-Y

    Mankind Pharma Standalone December 2024 Net Sales at Rs 2,396.57 crore, up 1.61% Y-o-Y

  • Mankind Pharma drops 6% after net profit declines in Q3

    Mankind Pharma drops 6% after net profit declines in Q3

    Mankind Pharma's Q3 net profit was impacted by the $1.6 billion acquisition of Bharat Serums and Vaccines (BSV), which came into effect from October.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347